Pet Care
Unveil 7 Elanco vs Zoetis Breakthroughs for Pet Health
Elanco’s Q1 2026 earnings per share rose sharply because its poultry-antiparasite line lifted overall profitability. The boost reflects a broader shift toward disease-control products that protect both livestock and companion animals, while investors watch margins tighten across the veterinary sector. Medical Disclaimer: This article is for informational purposes only